We provide you with 20 years of free, institutional-grade data for ZLAB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ZLAB. Explore the full financial landscape of ZLAB stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Chen Yajing | Initial | 2023-07-17 | |||
| Chen Kai-Xian | Sale | -1,409 | $62.18 | $87,612 | 2022-02-15 |
| DIEKMAN JOHN D | Sale | -1,000 | $50.17 | $50,170 | 2022-02-07 |
| Lis William | Sale | -1,926 | $53.4 | $102,848 | 2022-01-21 |
| WIRTH PETER | Grant, award...etc | 7,763 | 2022-01-04 | ||
| Lis William | Grant, award...etc | 7,763 | 2022-01-04 | ||
| MOULDER LEON O JR | Grant, award...etc | 7,763 | 2022-01-04 | ||
| DIEKMAN JOHN D | Grant, award...etc | 7,763 | 2022-01-04 | ||
| Chen Kai-Xian | Grant, award...etc | 7,763 | 2022-01-04 | ||
| Reinhart Harald | Sale | -5,903 | $69.23 | $408,665 | 2021-12-30 |
| Reinhart Harald | Grant, award...etc | 30,000 | 2021-12-27 | ||
| WIRTH PETER | Open Market Purchase | 4,000 | $71.36 | 2021-12-08 | |
| Sandler Alan B. | Sale | -2,075 | $71.23 | $147,802 | 2021-12-03 |
| Edmondson Frazor Titus III | Sale | -1,181 | $140.29 | $165,682 | 2021-12-03 |
| GAYNOR RICHARD | Grant, award...etc | 8,912 | 2021-11-22 | ||
| DIEKMAN JOHN D | Sale | -1,000 | $91.65 | $91,650 | 2021-11-08 |
| Fu Tao | Sale | -10,000 | $104.49 | $1,044,900 | 2021-10-29 |
| Morrison Scott W | Grant, award...etc | 7,345 | 2021-10-18 | ||
| Fu Tao | Sale | -10,000 | $102.02 | $1,020,200 | 2021-10-14 |
| Fu Tao | Sale | -10,000 | $105.55 | $1,055,500 | 2021-10-01 |
| Fu Tao | Sale | -19,932 | $134.09 | $2,672,682 | 2021-09-27 |
| Fu Tao | Sale | -9,900 | $124.98 | $1,237,302 | 2021-09-16 |
| Fu Tao | Derivatives Exercise | 10,000 | 2021-09-16 | ||
| Reinhart Harald | Sale | -10,000 | $137.39 | $1,373,900 | 2021-09-10 |
| Reinhart Harald | Derivatives Exercise | 10,000 | 2021-09-10 | ||
| Reinhart Harald | Sale | -10,000 | $143 | $1,430,000 | 2021-09-08 |
| Reinhart Harald | Derivatives Exercise | 10,000 | 2021-09-08 | ||
| Du Ying | Sale | -29,785 | $143.25 | $4,266,701 | 2021-09-08 |
| Du Ying | Sale | -81,326 | $143.77 | $11,692,239 | 2021-09-03 |
| Du Ying | Derivatives Exercise | 111,111 | 2021-09-03 | ||
| Fu Tao | Sale | -10,000 | $141.92 | $1,419,200 | 2021-08-26 |
| Fu Tao | Derivatives Exercise | 10,000 | 2021-08-26 | ||
| Reinhart Harald | Sale | -16,000 | $135 | $2,160,000 | 2021-08-25 |
| Reinhart Harald | Derivatives Exercise | 16,000 | 2021-08-25 | ||
| DIEKMAN JOHN D | Sale | -1,000 | $149.5 | $149,500 | 2021-08-05 |
The information provided in this report about ZLAB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zai Lab Limited(NASDAQ:ZLAB) 
Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops, and commercializes therapeutics to treat oncology, autoimmune, and infectious diseases in China. The company offers ZEJULA for the treatment of breast cancer and non-small cell lung cancer (NSCLC); and Optune, a cancer ther...
Website: http://www.zailaboratory.com
Founded: 2013
Full Time Employees: 859
Sector: Healthcare
Industry: Biotechnology